Every round, fund close and exit we can source, with the article it was reported in and what it actually said.
WeedRemeed, a drone-image weed detection platform built by the Centre for Invasive Species Solutions with 2pi Software, becomes easier to use, backed by a government grant and ACEN Australia's social investment support.
Profile of a Sydney-based medical device maker developing a hydrogel condom, noting its human safety trial, manufacturing build-out, patent portfolio and grant backing.
Two raises reported: Superhero has banked $20m of a hoped $30m round led by Salter Brothers at a $176m valuation, while New Zealand crime-intelligence startup Azonic took NZ$1m in a Blackbird-led pre-seed.
Healthcare AI vendor Arintra has banked $25m in Series B funding, led by Define Ventures, as prior backers such as Peak XV Partners, Y Combinator and others return; total backing now stands at $51m.
MUFG's pension services arm has signed a binding deed to buy GROW Inc, which provides superannuation administration technology in Australia; completion awaits approvals, the price is undisclosed, and client fund HESTA backs the move.
Also Australian FinTech
Results story: Tinybeans' completed Qeepsake acquisition lifted subscribers about 80% and drove positive EBITDA, Qeepsake's former CEO now leads Tinybeans, and further acquisitions are flagged.
MUFG's pensions arm has struck a binding agreement to acquire Grow Inc, a Sydney-founded superannuation administration startup whose shareholders — among them HESTA, Five V Capital and AirTree Ventures — must still approve the deal.
AVA Risk Group, an Australian security tech firm, took A$7 million in debt funding from Hale Capital and named Bryant Henson group CEO as annual revenue declined and its US push continued.
Main Sequence explains its decision to back Facet Amtech again alongside Uniseed in a $3 million round, funding the startup's water-based ammonia catalyst work and its first pilot plant.
Also AgFunderNews·Dealroom
Blackbird is weighing an early sale of its Canva stake through continuation funds, while Airtree's longtime backers are pushing it to return profits; no deal has been done.
Melbourne pharma Clinuvel is weighing a restructure into a US holding company listed only on Nasdaq and an ASX exit, weeks after completing a Nasdaq ADS uplisting, alongside a tenth straight annual profit.
Queensland feedlot cattle are being swabbed for BRD bacteria to support AgriCureX's phage and genomics research into antibiotic alternatives, a project MLA co-funds, with a first trial planned for mid-2027.
Agtech firm AirAgri has released a WhatsApp channel for on-farm safety and biosecurity reporting, timed to National Biosecurity Week and enabled by Telstra's satellite-to-mobile expansion, with founder James Diamond explaining the adoption rationale.
YesPress profile of Amy Errett, who moved from banking and Maveron venture investing to launch hair-color brand Madison Reed, and later joined the True Ventures investment team.
US infrastructure investor DigitalBridge has agreed to acquire PLUS ES, a major Australian smart meter provider running about two million meters, via its managed vehicle, with the deal still awaiting regulatory approvals.
Also DealStreetAsia
DigitalBridge has reportedly been chosen as the leading bidder for Ausgrid's Plus Es, the largest holder of utility smart meters, in what would be the New York-listed investor's first major Australian deal.
Street Talk reports L Catterton is in exclusive due diligence to buy Byron Bay dog food brand Eureka Pet Co, which earlier this year brought in Miras Capital to seek a capital partner.
Mesoblast's yearly report shows revenue leaping on first-year American sales of Ryoncil, losses narrowing, and a US$125 million debt refinancing, with its spinal disc trial fully recruited ahead of 2027 data.
Edge Early Learning, a Brisbane childcare chain backed by HEAL Partners, Centennial Property Group and Normanby Capital, has gone into administration under KordaMentha following a rental standoff with Arena REIT, its landlord.
Bigdatr has released a compliance platform letting Australian advertising regulators screen creative against industry codes, assign risk ratings, and review concerning ads shortly after publication.
Entropy Neurodynamics has agreed with UCSF to run a US Phase 2 trial of its psilocin drug TRP-8803 against escitalopram in young adults with depression, pending FDA clearance, with Swinburne and BioCina supporting.
Melbourne biotech Starpharma grew annual revenue on a Genentech licence payment, cut its loss, and completed a $30 million entitlement offer, giving it cash into 2028 to advance its cancer pipeline.
The two diagnostics companies have entered early-stage merger talks aiming to combine rapid pathogen testing with gut microbiome analysis, though both stress the discussions are preliminary with no terms agreed.
Administrators from KordaMentha now control childcare operator Edge Early Learning after a failed rescue, despite April cash support from its biggest shareholder, HEAL Partners.
Frasers Group, owned by British billionaire Mike Ashley, has demanded the resignation of Accent Group's chairman Lawrence Myers, intensifying its attack on the sports retail owner's board during its takeover bid.
AFR's Street Talk column reports childcare operator Edge Early Learning is heading toward administration despite an April funding injection from its biggest backer, HEAL Partners.
FleetPartners has received a A$3.85-per-share buyout proposal from a Sumitomo-led consortium, topping ORIX and Element Fleet's bids but trailing SG Fleet's, as a four-way contest for the Australian vehicle lessor continues.
Report on OpenAI's Sydney Founder Day profiling two school-student founders: one whose gaming-advertising venture has raised pre-seed funding, and one building a platform helping small businesses coordinate their tools.
Melbourne biotech ImmunoBiota Therapeutics, a Monash University spinout, is developing an oral type 1 diabetes treatment and seeking seed funding for paediatric trials; its founder won a Diabetes Australia innovation prize.
Blackbird has locked in a second billion-dollar fund — its sixth, slightly bigger than the last — bringing in new institutional backers, and the article recalls portfolio wins, writedowns and failures.
OpenAI has handed Australian founders, including two school students, credits worth over $5.5 million; the piece also notes Firmus's $15 billion valuation after a big raise and rising business AI adoption.
The federal NRFC has lent $120 million to prefab apartment maker Built Living, which has also drawn $100 million equity from Wesfarmers and a $20 million WA government grant.
MA Financial Group announces the appointment of Professor David Lloyd as an independent director to its board, effective 21 August 2026, citing his governance and leadership experience.
Banyan Software has bought retention marketing firm CRMA and will pair it with its Australian platform Harrier National; terms undisclosed, with CRMA's founder remaining to guide the business.
Street Talk reports Sydney adviser Miras Capital is seeking a new part-owner for pet food business Eureka Pet Co, sounding out private equity and strategic buyers at up to $40 million.
Algae producer Genesis Group has merged with pet nutrition firm Proudi, a combination the company expects will double its revenue; Proudi founder Dennis King joins the Genesis board as a director.
Melbourne investment firm Salter Brothers has joined a fresh capital raise for share-trading platform Superhero, which the report says is heading toward a $186 million valuation.
Also Cut Through Venture
Profile of SouthernCrossAI, which has floated on the ASX and raised $40 million for its onshore AI compute push, plus a DDN partnership; founder David Keane argues Australians should keep data and value onshore.
Yeppoon manufacturer CQ Fibreglass Direct is granted up to A$113,000 by the Queensland Government, the first project funded under its manufacturing modernisation programme, to install automated fibre composite equipment.
Dealroom reports FireFly Resources has begun an equity raise, with a further shareholder purchase plan planned, to fund feasibility work and drilling at its Canadian copper-gold project ahead of a mid-2027 development decision.
Disability services operator 4lifeskills has been bought by sector peer St Jude's Health Care Services after sliding into administration, keeping the Western Australian business's support services running under fresh ownership.
University of Wollongong researchers won government funding for a quantum photon-counting cancer imaging system and partnered with radiotherapy maker Elekta, moving the technology toward clinical trials.
Eight Australian companies make Forbes Asia's annual 100 To Watch list; the piece profiles each and recaps recent raises across climate tech, health and software.
Filings show Canva backed Sharon AI's US$103 million December 2025 raise with Regal, Ellerston, Digital Alpha and others; the Sydney compute provider has since floated on Nasdaq and raised US$2.15 billion more.
Also Dealroom
European regulators have cleared Neuren's Rett syndrome drug DAYBU, the first such treatment authorised in the EU, with milestone payments due to the Melbourne biotech from licence partner Acadia.
Blackbird announces its new early-stage and growth funds have brought in A$1.05 billion, reflecting on early cheques, portfolio outcomes like Eucalyptus's sale, and new international backers.
Also Dealroom·Dealroom·AFR Technology·Startup Daily·Business News Australia·Forbes Australia·Forbes Australia·Forbes Australia·Dealroom·This Week in Australian Startups
Blackbird, a venture capital firm based in Australia, has raised 752 million dollars from backers across Asia; only the headline is visible, as the body sits behind registration.
Acrux has hired Dr Jolanta Airey as chief medical officer, adding clinical leadership as the company prepares late-stage trials in the United States for its women's testosterone therapy.
Avecho Biotechnology brings in a former CSL dealmaking executive as a consultant to help license its Phase 3 CBD insomnia capsule internationally.
Morgan Stanley and Schroders have committed money to Blackbird Ventures' new $1b fund; the piece also recalls Airtree's $650m fifth fund drawing US institutional backing last year.